优化针对RNA聚合酶PA-PB1异构分子化的强效,广谱和特异性抗流感化合物
Anna Bonomini1, Tommaso Felicetti2, Martina Pacetti2
1Department of Molecular Medicine, University of Padua, 35121, Padua, Italy.
European journal of medicinal chemistry
|August 17, 2024
概括
针对流感病毒的新型小分子RNA依赖RNA聚合酶 (RdRP) 是有前途的. 化合物43和45通过抑制PA-PB1亚单元异体化来破坏病毒复制,提供潜在的新型抗流感疗法.
科学领域:
- 病毒学 病毒学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 流感病毒 (IV) 构成流行病风险,现有的疫苗提供部分保护,有限的抗病毒药物面临耐药性.
- 目前的流感治疗方法不足,需要开发新的治疗策略.
研究的目的:
- 开发针对流感病毒RNA依赖RNA聚合酶 (RdRP) 的新型小分子抑制剂.
- 优化化合物,以提高对流感A和B菌株的疗效.
主要方法:
- 一个循环甲基-3-碳胺化合物的药用化学优化.
- 测试用于评估针对流传性流感菌株的抗病毒活性.
- 机制研究,包括生物物理测定,以评估目标参与和ADME分析.
主要成果:
- 对抗甲型和乙型流感病毒具有纳米分子活性的强效抑制剂,化合物43和45的鉴定.
- 证明 43 和 45 化合物通过破坏 PA-PB1 子单元异体化来抑制病毒 RdRP 活性.
- 与最初的化合物相比,化合物45表现出更好的药理动力学特性.
结论:
- 化合物43和45代表了新型抗流感疗法的有希望的候选者.
- 抑制PA-PB1异体化是一种可行的策略,用于开发新的流感抗病毒药物.
- 由于其有效性和改善的ADME概况,需要进一步开发45化合物.
相关概念视频
Eukaryotic RNA Polymerases
24.0K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
24.0K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Transcription Initiation
16.3K
Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
The promoters and enhancers and their accessory proteins allow tight regulation of...
16.3K
Transcription Attenuation in Prokaryotes
15.2K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
15.2K
Bacterial RNA Polymerase
29.4K
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
29.4K


